Dr Manfred Beleut

      

Dr Manfred Beleut

Consulting Editor: Manfred Beleut (PhD)

CEO Medoderm GmbH, Mainz, Germany

Dr. Manfred Beleut brings significant experience in the fields of oncology, biomarkers and translational pathology.
As a trained molecular biologist, he performed his postdoctoral work at the Zurich University Hospital with focus on systems biology, microarrays and molecular aspects of renal cell carcinogenesis.
 
Dr. Beleut holds a PhD from the University of Lausanne, has experience in both international academic and non-academic industries, and brings expertise in long standing patient care. He has been awarded grants from Roche, Pfizer, and the DAAD (German Academic Exchange Service). In 2007, he was selected by BioVision – The World Life Science Forum – as one of 100 most promising future bioleaders to form the BioVision Nxt. ”Class of 2007“.
 
Dr. Beleut is a member of national and international cancer societies, serves as peer-reviewer for diverse scientific journals and is author of patents, research articles and book chapters covering basic and translational aspects of cancer research. He is also actively involved in European Union supported technology transfer projects for improving the medical and scientific infrastructure in Eastern Europe. As a visiting professor at the Victor Babes University of Medicine and Pharmacy Timisoara, he successfully initiated and co-founded the first Romanian biobank for rare skin diseases. Current collaborative research projects are addressing molecular cytogenetic and gene expression profiling of inflammatory dermatoses and cutaneous lymphoma and wound healing.